<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>US FDA Quality Metrics Guidelines Update</title><link>/community-hubs/deltav-community-connect/b/ops-weblog/posts/us-fda-quality-metrics-guidelines-update-515830796</link><description>Author: Eric Kuebler 
 
 Since the Continued Process Verification (CPV) guidance in 2011, the U.S. Food and Drug Administration (FDA) has been talking quality and verifying process state of control.
 
 Now the FDA is getting around to defining what that</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>